{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:01:31Z","timestamp":1791576091823,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T00:00:00Z","timestamp":1359504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T00:00:00Z","timestamp":1359504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12672-013-0134-1","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T12:18:26Z","timestamp":1359461906000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Altered PTEN, ATRX, CHGA, CHGB, and TP53 Expression Are Associated with Aggressive VHL-Associated Pancreatic Neuroendocrine Tumors"],"prefix":"10.1007","volume":"4","author":[{"given":"Allison B.","family":"Weisbrod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Quezado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"key":"134_CR1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/978-1-4419-6448-9_22","volume":"685","author":"JJ Kim","year":"2010","unstructured":"Kim JJ, Rini BI, Hansel DE (2010) Von Hippel Lindau syndrome. Adv Exp Med Biol 685:228\u2013249, Epub 2010\/08\/07. PubMed PMID: 20687511","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"134_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/PAP.0b013e31816f852e","volume":"15","author":"BM Shehata","year":"2008","unstructured":"Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H (2008) Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol 15(3):165\u2013171. doi:10.1097\/PAP.0b013e31816f852e, Epub 2008\/04\/25. PubMed PMID: 18434768","journal-title":"Adv Anat Pathol"},{"key":"134_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1294.002","volume":"1014","author":"G Kloppel","year":"2004","unstructured":"Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13\u201327, Epub 2004\/05\/22. PubMed PMID: 15153416","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"134_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindi","year":"2006","unstructured":"Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395\u2013401. doi:10.1007\/s00428-006-0250-1, Epub 2006\/09\/13. PubMed PMID: 16967267; PubMed Central PMCID: PMC1888719","journal-title":"Virchows Arch"},{"issue":"Suppl 1","key":"134_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1530\/ERC-11-0013","volume":"18","author":"G Kloppel","year":"2011","unstructured":"Kloppel G (2011) Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 18(Suppl 1):S1\u2013S16. doi:10.1530\/ERC-11-0013, Epub 2011\/10\/26. PubMed PMID: 22005112","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"134_CR6","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1097\/PAS.0b013e31805f675d","volume":"31","author":"AM Schmitt","year":"2007","unstructured":"Schmitt AM, Anlauf M, Rousson V, Schmid S, Kofler A, Riniker F et al (2007) WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 31(11):1677\u20131682. doi:10.1097\/PAS.0b013e31805f675d, Epub 2007\/12\/07. PubMed PMID: 18059224","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"134_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/bjs.6051","volume":"95","author":"L Fischer","year":"2008","unstructured":"Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H et al (2008) Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 95(5):627\u2013635. doi:10.1002\/bjs.6051, Epub 2008\/02\/29. PubMed PMID: 18306152","journal-title":"Br J Surg"},{"issue":"1","key":"134_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.humpath.2008.06.005","volume":"40","author":"S La Rosa","year":"2009","unstructured":"La Rosa S, Klersy C, Uccella S, Dainese L, Albarello L, Sonzogni A et al (2009) Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 40(1):30\u201340. doi:10.1016\/j.humpath.2008.06.005, Epub 2008\/08\/22. PubMed PMID: 18715612","journal-title":"Hum Pathol"},{"issue":"6","key":"134_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/modpathol.2010.58","volume":"23","author":"A Scarpa","year":"2010","unstructured":"Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R et al (2010) Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 23(6):824\u2013833. doi:10.1038\/modpathol.2010.58, Epub 2010\/03\/23. PubMed PMID: 20305616","journal-title":"Mod Pathol"},{"issue":"6021","key":"134_CR10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A et al (2011) DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331(6021):1199\u20131203. doi:10.1126\/science.1200609, Epub 2011\/01\/22. PubMed PMID: 21252315; PubMed Central PMCID: PMC3144496","journal-title":"Science"},{"issue":"1","key":"134_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2010.02.011","volume":"165","author":"GM Portela-Gomes","year":"2010","unstructured":"Portela-Gomes GM, Grimelius L, Wilander E, Stridsberg M (2010) Granins and granin-related peptides in neuroendocrine tumours. Regul Pept 165(1):12\u201320. doi:10.1016\/j.regpep.2010.02.011, Epub 2010\/03\/10. PubMed PMID: 20211659","journal-title":"Regul Pept"},{"issue":"2","key":"134_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4161\/isl.2.2.10807","volume":"2","author":"T Tomita","year":"2010","unstructured":"Tomita T (2010) Cleaved caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors: a potential marker for biological malignancy. Islets 2(2):82\u201388. doi:10.4161\/isl.2.2.10807, Epub 2010\/11\/26. PubMed PMID: 21099299","journal-title":"Islets"},{"issue":"5","key":"134_CR13","first-page":"456","volume":"62","author":"D Kajdaniuk","year":"2011","unstructured":"Kajdaniuk D, Marek B, Foltyn W, Kos-Kudla B (2011) Vascular endothelial growth factor (VEGF)\u2014part 2: in endocrinology and oncology. Endokrynol Pol 62(5):456\u2013464, Epub 2011\/11\/10. PubMed PMID: 22069107","journal-title":"Endokrynol Pol"},{"issue":"3","key":"134_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35106009","volume":"1","author":"T Soussi","year":"2001","unstructured":"Soussi T, Beroud C (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1(3):233\u2013240. doi:10.1038\/35106009, Epub 2002\/03\/21. PubMed PMID: 11902578","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"134_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","volume":"36","author":"S Yachida","year":"2012","unstructured":"Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R et al (2012) Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 36(2):173\u2013184. doi:10.1097\/PAS.0b013e3182417d36, Epub 2012\/01\/19. PubMed PMID: 22251937; PubMed Central PMCID: PMC3261427","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"134_CR16","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1210\/jc.2004-1234","volume":"89","author":"E Kebebew","year":"2004","unstructured":"Kebebew E, Peng M, Treseler PA, Clark OH, Duh QY, Ginzinger D et al (2004) Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells. J Clin Endocrinol Metab 89(12):6105\u20136111. doi:10.1210\/jc.2004-1234, Epub 2004\/12\/08. PubMed PMID: 15579766","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"134_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0002-9440(10)64624-X","volume":"157","author":"A Perren","year":"2000","unstructured":"Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S, Lees JA et al (2000) Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 157(4):1097\u20131103. doi:10.1016\/S0002-9440(10)64624-X, Epub 2000\/10\/06. PubMed PMID: 11021813; PubMed Central PMCID: PMC1850183","journal-title":"Am J Pathol"},{"issue":"12","key":"134_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1055\/s-0031-1291333","volume":"43","author":"M Krausch","year":"2011","unstructured":"Krausch M, Raffel A, Anlauf M, Schott M, Willenberg H, Lehwald N et al (2011) Loss of PTEN expression in neuroendocrine pancreatic tumors. Horm Metab Res 43(12):865\u2013871. doi:10.1055\/s-0031-1291333, Epub 2011\/11\/23. PubMed PMID: 22105477","journal-title":"Horm Metab Res"},{"issue":"2","key":"134_CR19","first-page":"139","volume":"10","author":"L Wang","year":"2002","unstructured":"Wang L, Ignat A, Axiotis CA (2002) Differential expression of the PTEN tumor suppressor protein in fetal and adult neuroendocrine tissues and tumors: progressive loss of PTEN expression in poorly differentiated neuroendocrine neoplasms. Appl Immunohistochem Mol Morphol 10(2):139\u2013146, Epub 2002\/06\/08. PubMed PMID: 12051632","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"134_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1677\/ERC-09-0204","volume":"17","author":"D O\u2019Toole","year":"2010","unstructured":"O\u2019Toole D, Couvelard A, Rebours V, Zappa M, Hentic O, Hammel P et al (2010) Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors. Endocr Relat Cancer 17(4):847\u2013856. doi:10.1677\/ERC-09-0204, Epub 2010\/06\/24. PubMed PMID: 20570957","journal-title":"Endocr Relat Cancer"},{"issue":"41","key":"134_CR21","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1038\/onc.2008.237","volume":"27","author":"MS Orloff","year":"2008","unstructured":"Orloff MS, Eng C (2008) Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 27(41):5387\u20135397. doi:10.1038\/onc.2008.237, Epub 2008\/09\/17. PubMed PMID: 18794875","journal-title":"Oncogene"},{"issue":"2","key":"134_CR22","first-page":"282","volume":"63","author":"ME Ginn-Pease","year":"2003","unstructured":"Ginn-Pease ME, Eng C (2003) Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Cancer Res 63(2):282\u2013286, Epub 2003\/01\/25. PubMed PMID: 12543774","journal-title":"Cancer Res"},{"issue":"Pt 3","key":"134_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1242\/jcs.022459","volume":"121","author":"SM Planchon","year":"2008","unstructured":"Planchon SM, Waite KA, Eng C (2008) The nuclear affairs of PTEN. J Cell Sci 121(Pt 3):249\u2013253. doi:10.1242\/jcs.022459, Epub 2008\/01\/25. PubMed PMID: 18216329","journal-title":"J Cell Sci"},{"issue":"1","key":"134_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","volume":"128","author":"WH Shen","year":"2007","unstructured":"Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP et al (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128(1):157\u2013170. doi:10.1016\/j.cell.2006.11.042, Epub 2007\/01\/16. PubMed PMID: 17218262","journal-title":"Cell"},{"issue":"6","key":"134_CR25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/hmg\/10.6.599","volume":"10","author":"LP Weng","year":"2001","unstructured":"Weng LP, Brown JL, Eng C (2001) PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet 10(6):599\u2013604, Epub 2001\/03\/07. PubMed PMID: 11230179","journal-title":"Hum Mol Genet"},{"issue":"18","key":"134_CR26","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1158\/0008-5472.CAN-05-1888","volume":"65","author":"JH Chung","year":"2005","unstructured":"Chung JH, Eng C (2005) Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65(18):8096\u20138100. doi:10.1158\/0008-5472.CAN-05-1888, Epub 2005\/09\/17. PubMed PMID: 16166282","journal-title":"Cancer Res"},{"issue":"2","key":"134_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","volume":"28","author":"E Missiaglia","year":"2010","unstructured":"Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, della Peruta M et al (2010) Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol 28(2):245\u2013255. doi:10.1200\/JCO.2008.21.5988, Epub 2009\/11\/18. PubMed PMID: 19917848","journal-title":"J Clin Oncol"},{"issue":"9","key":"134_CR28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/1541-7786.MCR-11-0302","volume":"9","author":"B Kucejova","year":"2011","unstructured":"Kucejova B, Pena-Llopis S, Yamasaki T, Sivanand S, Tran TA, Alexander S et al (2011) Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. Mol Cancer Res 9(9):1255\u20131265. doi:10.1158\/1541-7786.MCR-11-0302, Epub 2011\/07\/30. PubMed PMID: 21798997; PubMed Central PMCID: PMC3234675","journal-title":"Mol Cancer Res"},{"issue":"4","key":"134_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/modpathol.2010.222","volume":"24","author":"A von Teichman","year":"2011","unstructured":"von Teichman A, Comperat E, Behnke S, Storz M, Moch H, Schraml P (2011) VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. Mod Pathol 24(4):571\u2013578. doi:10.1038\/modpathol.2010.222, Epub 2010\/12\/15. PubMed PMID: 21151099","journal-title":"Mod Pathol"},{"issue":"14","key":"134_CR30","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4161\/cbt.8.14.8880","volume":"8","author":"BL Petrella","year":"2009","unstructured":"Petrella BL, Brinckerhoff CE (2009) PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. Cancer Biol Ther 8(14):1389\u20131401, Epub 2009\/06\/02. PubMed PMID: 19483472; PubMed Central PMCID: PMC2761525","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"134_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","volume":"659","author":"M Rosner","year":"2008","unstructured":"Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschlager M (2008) The mTOR pathway and its role in human genetic diseases. Mutat Res 659(3):284\u2013292. doi:10.1016\/j.mrrev.2008.06.001, Epub 2008\/07\/05. PubMed PMID: 18598780","journal-title":"Mutat Res"},{"issue":"Pt 17","key":"134_CR32","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1242\/jcs.01230jcs.01230","volume":"117","author":"AM Ishov","year":"2004","unstructured":"Ishov AM, Vladimirova OV, Maul GG (2004) Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI\/SNF protein ATRX. J Cell Sci 117(Pt 17):3807\u20133820. doi:10.1242\/jcs.01230jcs.01230, Epub 2004\/07\/15. PubMed PMID: 15252119","journal-title":"J Cell Sci"},{"issue":"5","key":"134_CR33","doi-asserted-by":"publisher","first-page":"a000661","DOI":"10.1101\/cshperspect.a000661","volume":"2","author":"V Lallemand-Breitenbach","year":"2010","unstructured":"Lallemand-Breitenbach V, de The H (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol 2(5):a000661. doi:10.1101\/cshperspect.a000661, Epub 2010\/05\/11. PubMed PMID: 20452955; PubMed Central PMCID: PMC2857171","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"134_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12035-010-8156-y","volume":"43","author":"P Salomoni","year":"2011","unstructured":"Salomoni P, Betts-Henderson J (2011) The role of PML in the nervous system. Mol Neurobiol 43(2):114\u2013123. doi:10.1007\/s12035-010-8156-y, Epub 2010\/12\/17. PubMed PMID: 21161613","journal-title":"Mol Neurobiol"},{"issue":"19","key":"134_CR35","doi-asserted-by":"publisher","first-page":"10635","DOI":"10.1073\/pnas.19376261001937626100","volume":"100","author":"Y Xue","year":"2003","unstructured":"Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S et al (2003) The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A 100(19):10635\u201310640. doi:10.1073\/pnas.19376261001937626100, Epub 2003\/09\/04. PubMed PMID: 12953102; PubMed Central PMCID: PMC196856","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"134_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tcb.2005.12.002","volume":"16","author":"P Salomoni","year":"2006","unstructured":"Salomoni P, Khelifi AF (2006) Daxx: death or survival protein? Trends Cell Biol 16(2):97\u2013104. doi:10.1016\/j.tcb.2005.12.002, Epub 2006\/01\/13. PubMed PMID: 16406523","journal-title":"Trends Cell Biol"},{"issue":"4","key":"134_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrgastro.2012.9","volume":"9","author":"RF de Wilde","year":"2012","unstructured":"de Wilde RF, Edil BH, Hruban RH, Maitra A (2012) Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy. Nat Rev Gastroenterol Hepatol 9(4):199\u2013208. doi:10.1038\/nrgastro.2012.9, Epub 2012\/02\/09. PubMed PMID: 22310917","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6041","key":"134_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1126\/science.1207313","volume":"333","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C et al (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333(6041):425. doi:10.1126\/science.1207313, Epub 2011\/07\/02. PubMed PMID: 21719641; PubMed Central PMCID: PMC3174141","journal-title":"Science"},{"issue":"2","key":"134_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.devcel.2009.12.017","volume":"18","author":"KD Kernohan","year":"2010","unstructured":"Kernohan KD, Jiang Y, Tremblay DC, Bonvissuto AC, Eubanks JH, Mann MR et al (2010) ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Dev Cell 18(2):191\u2013202. doi:10.1016\/j.devcel.2009.12.017, Epub 2010\/02\/18. PubMed PMID: 20159591","journal-title":"Dev Cell"},{"issue":"7","key":"134_CR40","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nsmb.2062","volume":"18","author":"S Iwase","year":"2011","unstructured":"Iwase S, Xiang B, Ghosh S, Ren T, Lewis PW, Cochrane JC et al (2011) ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. Nat Struct Mol Biol 18(7):769\u2013776. doi:10.1038\/nsmb.2062, Epub 2011\/06\/15. PubMed PMID: 21666679; PubMed Central PMCID: PMC3130887","journal-title":"Nat Struct Mol Biol"},{"key":"134_CR41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bse0370059","volume":"37","author":"RR Meehan","year":"2001","unstructured":"Meehan RR, Stancheva I (2001) DNA methylation and control of gene expression in vertebrate development. Essays Biochem 37:59\u201370, Epub 2002\/01\/05. PubMed PMID: 11758457","journal-title":"Essays Biochem"},{"issue":"1","key":"134_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrg1500","volume":"6","author":"MA Matzke","year":"2005","unstructured":"Matzke MA, Birchler JA (2005) RNAi-mediated pathways in the nucleus. Nat Rev Genet 6(1):24\u201335. doi:10.1038\/nrg1500, Epub 2005\/01\/05. PubMed PMID: 15630419","journal-title":"Nat Rev Genet"},{"issue":"4","key":"134_CR43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/hmg\/9.4.539","volume":"9","author":"NG Berube","year":"2000","unstructured":"Berube NG, Smeenk CA, Picketts DJ (2000) Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet 9(4):539\u2013547, Epub 2000\/03\/04. PubMed PMID: 10699177","journal-title":"Hum Mol Genet"},{"issue":"7","key":"134_CR44","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/sj.cdd.4401559","volume":"12","author":"AF Khelifi","year":"2005","unstructured":"Khelifi AF, D\u2019Alcontres MS, Salomoni P (2005) Daxx is required for stress-induced cell death and JNK activation. Cell Death Differ 12(7):724\u2013733. doi:10.1038\/sj.cdd.4401559, Epub 2005\/04\/30. PubMed PMID: 15861194","journal-title":"Cell Death Differ"},{"issue":"9","key":"134_CR45","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1245\/s10434-010-1006-3","volume":"17","author":"IM Modlin","year":"2010","unstructured":"Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M (2010) Chromogranin A\u2014biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol 17(9):2427\u20132443. doi:10.1245\/s10434-010-1006-3, Epub 2010\/03\/11. PubMed PMID: 20217257","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"134_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/(SICI)1096-9896(199804)184:4<414::AID-PATH1229>3.0.CO;2-U","volume":"184","author":"L Scopsi","year":"1998","unstructured":"Scopsi L, Sampietro G, Boracchi P, Collini P (1998) Argyrophilia and chromogranin A and B immunostaining in patients with sporadic medullary thyroid carcinoma. A critical appraisal of their prognostic utility. J Pathol 184(4):414\u2013419. doi:10.1002\/(SICI)1096-9896(199804)184:4<414::AID-PATH1229>3.0.CO;2-U, Epub 1998\/07\/17. PubMed PMID: 9664908","journal-title":"J Pathol"},{"issue":"2","key":"134_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1097-0045(19980201)34:2<113::AID-PROS5>3.0.CO;2-L","volume":"34","author":"G Pruneri","year":"1998","unstructured":"Pruneri G, Galli S, Rossi RS, Roncalli M, Coggi G, Ferrari A et al (1998) Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy. Prostate 34(2):113\u2013120. doi:10.1002\/(SICI)1097-0045(19980201)34:2<113::AID-PROS5>3.0.CO;2-L, Epub 1998\/02\/18. PubMed PMID: 9465942","journal-title":"Prostate"},{"issue":"3","key":"134_CR48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2559.1994.tb00515.x","volume":"24","author":"KW Schmid","year":"1994","unstructured":"Schmid KW, Helpap B, Totsch M, Kirchmair R, Dockhorn-Dworniczak B, Bocker W et al (1994) Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology 24(3):233\u2013239, Epub 1994\/03\/01. PubMed PMID: 7515371","journal-title":"Histopathology"},{"issue":"10","key":"134_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1600-0463.2004.t01-1-apm1121003.x","volume":"112","author":"GM Portela-Gomes","year":"2004","unstructured":"Portela-Gomes GM, Stridsberg M, Grimelius L, Falkmer UG, Falkmer S (2004) Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas. An immunohistochemical study with region-specific antibodies. APMIS 112(10):663\u2013673. doi:10.1111\/j.1600-0463.2004.t01-1-apm1121003.x, Epub 2004\/12\/17. PubMed PMID: 15601318","journal-title":"APMIS"},{"issue":"10","key":"134_CR50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00000478-200110000-00006","volume":"25","author":"GM Portel-Gomes","year":"2001","unstructured":"Portel-Gomes GM, Grimelius L, Johansson H, Wilander E, Stridsberg M (2001) Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies. Am J Surg Pathol 25(10):1261\u20131267, Epub 2001\/11\/02. PubMed PMID: 11688460","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"134_CR51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/002215540104900408","volume":"49","author":"GM Portela-Gomes","year":"2001","unstructured":"Portela-Gomes GM, Stridsberg M (2001) Selective processing of chromogranin A in the different islet cells in human pancreas. J Histochem Cytochem 49(4):483\u2013490, Epub 2001\/03\/22. PubMed PMID: 11259451","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"134_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1748-1716.2007.01806.x","volume":"192","author":"M Montero-Hadjadje","year":"2008","unstructured":"Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y (2008) Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192(2):309\u2013324. doi:10.1111\/j.1748-1716.2007.01806.x, Epub 2007\/11\/17. PubMed PMID: 18005393","journal-title":"Acta Physiol (Oxf)"},{"issue":"50","key":"134_CR53","doi-asserted-by":"publisher","first-page":"49699","DOI":"10.1074\/jbc.M309307200M309307200","volume":"278","author":"EC Thrower","year":"2003","unstructured":"Thrower EC, Choe CU, So SH, Jeon SH, Ehrlich BE, Yoo SH (2003) A functional interaction between chromogranin B and the inositol 1,4,5-trisphosphate receptor\/Ca2+ channel. J Biol Chem 278(50):49699\u201349706. doi:10.1074\/jbc.M309307200M309307200, Epub 2003\/09\/25. PubMed PMID: 14506248","journal-title":"J Biol Chem"},{"key":"134_CR54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-1-4020-6191-2_15","volume":"45","author":"T Capiod","year":"2007","unstructured":"Capiod T, Shuba Y, Skryma R, Prevarskaya N (2007) Calcium signalling and cancer cell growth. Subcell Biochem 45:405\u2013427, Epub 2008\/01\/16. PubMed PMID: 18193646","journal-title":"Subcell Biochem"},{"issue":"2","key":"134_CR55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0955-0674(03)00003-6","volume":"15","author":"CL Brooks","year":"2003","unstructured":"Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15(2):164\u2013171, Epub 2003\/03\/22. PubMed PMID: 12648672","journal-title":"Curr Opin Cell Biol"},{"issue":"6630","key":"134_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387(6630):299\u2013303. doi:10.1038\/387299a0","journal-title":"Nature"},{"issue":"12","key":"134_CR57","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1128\/MCB.10.12.6565","volume":"10","author":"G Shaulsky","year":"1990","unstructured":"Shaulsky G, Goldfinger N, Ben-Ze\u2019ev A, Rotter V (1990) Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol 10(12):6565\u20136577, Epub 1990\/12\/01. PubMed PMID: 2247074; PubMed Central PMCID: PMC362933","journal-title":"Mol Cell Biol"},{"issue":"7","key":"134_CR58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/j.1460-2075.1983.tb01543.x","volume":"2","author":"V Rotter","year":"1983","unstructured":"Rotter V, Abutbul H, Ben-Ze\u2019ev A (1983) P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts. EMBO J 2(7):1041\u20131047, Epub 1983\/01\/01. PubMed PMID: 6354706; PubMed Central PMCID: PMC555232","journal-title":"EMBO J"},{"issue":"6312","key":"134_CR59","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/349802a0","volume":"349","author":"JV Gannon","year":"1991","unstructured":"Gannon JV, Lane DP (1991) Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349(6312):802\u2013806. doi:10.1038\/349802a0, Epub 1991\/02\/28. PubMed PMID: 2000149","journal-title":"Nature"},{"issue":"18)","key":"134_CR60","first-page":"2054","volume":"5","author":"JS Roe","year":"2006","unstructured":"Roe JS, Youn HD (2006) The positive regulation of p53 by the tumor suppressor VHL. Cell Cycle 5(18)):2054\u20132056, Epub 2006\/09\/14. PubMed PMID: 16969113","journal-title":"Cell Cycle"},{"issue":"2","key":"134_CR61","first-page":"329","volume":"6","author":"T Kawasaki","year":"1999","unstructured":"Kawasaki T, Bilim V, Takahashi K, Tomita Y (1999) Infrequent alteration of p53 pathway in metastatic renal cell carcinoma. Oncol Rep 6(2):329\u2013333, Epub 1999\/02\/19. PubMed PMID: 10022999","journal-title":"Oncol Rep"},{"issue":"6","key":"134_CR62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001622-199511000-00013","volume":"7","author":"SW Lowe","year":"1995","unstructured":"Lowe SW (1995) Cancer therapy and p53. Curr Opin Oncol 7(6):547\u2013553, Epub 1995\/11\/01. PubMed PMID: 8547404","journal-title":"Curr Opin Oncol"},{"issue":"Pt 1","key":"134_CR63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1242\/jcs.101.1.183","volume":"101","author":"CA Midgley","year":"1992","unstructured":"Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM (1992) Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 101(Pt 1):183\u2013189, Epub 1992\/01\/01. PubMed PMID: 1569122","journal-title":"J Cell Sci"},{"issue":"15","key":"134_CR64","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1073\/pnas.89.15.7262","volume":"89","author":"UM Moll","year":"1992","unstructured":"Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A 89(15):7262\u20137266, Epub 1992\/08\/01. PubMed PMID: 1353891; PubMed Central PMCID: PMC49686","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8691","key":"134_CR65","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0140-6736(90)90801-B","volume":"335","author":"R Iggo","year":"1990","unstructured":"Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335(8691):675\u2013679, Epub 1990\/03\/24. PubMed PMID: 1969059","journal-title":"Lancet"},{"issue":"6","key":"134_CR66","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","volume":"142","author":"JA Blansfield","year":"2007","unstructured":"Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR et al (2007) Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 142(6):814\u2013818. doi:10.1016\/j.surg.2007.09.012, discussion 8 e1-2. Epub 2007\/12\/08. PubMed PMID: 18063061","journal-title":"Surgery"},{"issue":"5","key":"134_CR67","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1097\/01.ju.0000091807.02246.f3","volume":"170","author":"DS Yu","year":"2003","unstructured":"Yu DS, Hsieh DS, Chang SY (2003) Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A. J Urol 170(5):2031\u20132035. doi:10.1097\/01.ju.0000091807.02246.f3, Epub 2003\/10\/09. PubMed PMID: 14532847","journal-title":"J Urol"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-013-0134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-013-0134-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-013-0134-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-013-0134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T18:16:52Z","timestamp":1644171412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-013-0134-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s12672-013-0134-1","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,30]]},"assertion":[{"value":"2 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}